IL6 and rheumatoid arthritis: Pro-inflammatory cytokines implicated in RA, such as tumor necrosis factor alpha (TNF-a) and interleukin-6 (IL-6), promote atherosclerotic processes by directly damaging the endothelium of vascular tissue through the modulation of classic risk factors and by interfering with the vascular repair system.